Skip to main content
Premium Trial:

Request an Annual Quote

BioMachines' New Proteomics Services Arm Will Use Nonlinear Dynamics' 2D-Analysis Tech

NEW YORK (GenomeWeb News) – BioMachines will use Nonlinear Dynamics’ 2D analysis technology to support its new protein analysis service, Nonlinear Dynamics said today.
 
BioMachines said that its newly created Applied Proteomics Services Division will use Nonlinear’s SameSpots 2D analysis technology.
 
“We implemented the SameSpots approach in our 2D image analysis workflow as we recognize the significant time savings it offers on what is a labor-intensive process,” BioMachines CEO Tom Larrichio said in a statement.
 
“Applying SameSpots to the aligned images vastly reduces, and even removes in some cases the need for post-analysis editing," he said.
 

Financial terms of the deal were not disclosed.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.